tiprankstipranks
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market

Janux Therapeutics Inc (JANX) Stock Investors

167 Followers
Based on 731,863 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold JANX
On average, investors allocate 0.00% of their portfolios to JANX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 731,863 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding JANX

2.1%
Last 7
Days
34.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding JANX, out of 731,863 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

JANX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
5.26%
$47.67
Increased
0.26%
$39.53
Based on the activity of 13,747 investors who made their portfolios public
The table shows changes in JANX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

JANX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Riot Platforms
5.01%
-0.23%
+3.40%
2.49B
Financial
UiPath
3.52%
-0.43%
+2.09%
10.95B
Technology
Marathon Digital Holdings
5.43%
-1.17%
-0.88%
4.54B
Financial
Arista Networks
4.15%
-0.43%
-2.17%
80.04B
Technology
SoundHound AI, Inc Class A
5.10%
+0.52%
+2.94%
1.36B
Technology
Coherus Biosciences
2.62%
-1.35%
-5.19%
233.81M
Healthcare
Trade Desk
4.74%
+0.10%
-1.36%
41.76B
Technology
Micron
5.66%
-0.05%
+5.95%
121.48B
Technology
Merck & Company
4.17%
-0.44%
+1.62%
326.20B
Healthcare
XPeng, Inc. ADR
5.25%
-1.04%
-4.03%
7.59B
Consumer Cyclical
Based on the activity of 731,863 active portfolios
Open your Smart Portfolio

JANX Investor Analysis

JANX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
5.3%
of JANX holders
are under 35
Average Segment Performance
Average P/E Ratio56.32
Beta6.59
Dividend Yield6.13%
JANX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
42.1%
of JANX holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.35
Beta11.34
Dividend Yield17.67%
JANX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
52.6%
of JANX holders
are over 55
Average Segment Performance
Average P/E Ratio52.26
Beta4.21
Dividend Yield22.32%
Overview of age group and performance of JANX stock investors
See who invests in JANX according to age group and performance.

FAQ

How many retail Investors hold JANX?
<0.1% of TipRanks' retail investors hold JANX in their portfolios.
    What is JANX Investor Sentiment?
    JANX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of JANX in the last 7 days?
      ▲ 2.1% of TipRanks' retail investors changed their holding of JANX in the last 7 days.
        What percentage of retail investors changed their holding of JANX in the last 30 days?
        ▲ 34.7% of TipRanks' retail investors changed their holding of JANX in the last 30 days.
          What is the average age of retail investors who hold JANX?
          The average age of JANX Holders is over 55.
            What other stocks have JANX investors also bought?
            JANX Investors also bought RIOT, PATH, MARA, ANET, SOUN, CHRS, TTD, MU, MRK, XPEV.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              ARAYAccuray
              AGENAgenus
              BAXBaxter International
              BDXBecton Dickinson
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis